Health Canada drug identification number

DIN 02442175 — MOVANTIK 25 MG

MOVANTIK is a tablet of Naloxegol marketed by KNIGHT THERAPEUTICS INC.. The full Naloxegol monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02442175
Brand name
MOVANTIK
Active ingredient
Naloxegol
Strength
25 MG
Dosage form
TABLET
Route
ORAL
Manufacturer
KNIGHT THERAPEUTICS INC.
Health Canada status
MARKETED
Drug class
Peripherally acting mu-opioid receptor antagonist (PAMORA)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Naloxegol products

DINBrandStrengthFormManufacturerStatus
02442167 MOVANTIK 12.5 MG TABLET KNIGHT THERAPEUTICS INC. MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.